Research output per year
Research output per year
Personal profile
Expertises
Haematology
Multiple myeloma and other plasma cell disorders
Main research areas
Multiple myeloma
Current research
I'm primary investigator in several national and international clinical trials for patients with multiple myeloma
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Carsten Helleberg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group
Gregersen, H., Peceliunas, V., Remes, K., Schjesvold, F., Abildgaard, N., Nahi, H., Andersen, N. F., Vangsted, A. J., Klausen, T. W., Helleberg, C., Carlson, K., Frølund, U. C., Axelsson, P., Stromberg, O., Blimark, C. H., Crafoord, J., Tsykunova, G., Eshoj, H. R., Waage, A., Hansson, M., & 1 others, Jan 2022, In: European Journal of Haematology. 108, 1, p. 34-44 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
Schmitz, A., Brøndum, R. F., Johnsen, H. E., Mellqvist, U. H., Waage, A., Gimsing, P., op Bruinink, D. H., van der Velden, V., van der Holt, B., Hansson, M., Andersen, N. F., Frølund, U. C., Helleberg, C., Schjesvold, F. H., Ahlberg, L., Gulbrandsen, N., Andreasson, B., Lauri, B., Haukas, E., Bødker, J. S., & 7 others, Dec 2022, In: BMC Cancer. 22, 1, 147.Research output: Contribution to journal › Journal article › Research › peer-review
-
The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy
Szabo, A. G., Thorsen, J., Iversen, K. F., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, L. M. R., Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Teodorescu, E. M., Dokhi, M., Kurt, E., Strandholdt, C. N., Andersen, M. K. & Vangsted, A. J., 1 Mar 2022, In: American Journal of Hematology. 97, 3, p. E117-E120Research output: Contribution to journal › Letter › peer-review
-
Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio
Szabo, A. G., Klausen, T. W., Abildgaard, N., Gregersen, H., Silkjær, T., Pedersen, P. T., Pedersen, R. S., Helleberg, C., Hermansen, E., Schnack, B. I. & Vangsted, A. J., 7 Apr 2021, In: Blood Cancer Journal. 11, 4, p. 70 70.Research output: Contribution to journal › Letter › peer-review
-
Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients
Højholt, K. L., Gregersen, H., Szabo, A. G., Klausen, T. W., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Rahbek Gjerdrum, L. M., Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Iversen, K. F., Teodorescu, E. M., Kurt, E., Strandholdt, C., Andersen, M. K. & Vangsted, A. J., Oct 2021, In: Hematological Oncology. 39, 4, p. 521-528 8 p.Research output: Contribution to journal › Journal article › Research › peer-review